Literature DB >> 22560527

A framework for fibromyalgia management for primary care providers.

Lesley M Arnold1, Daniel J Clauw, L Jean Dunegan, Dennis C Turk.   

Abstract

Fibromyalgia is a chronic widespread pain disorder commonly associated with comorbid symptoms, including fatigue and nonrestorative sleep. As in the management of other chronic medical disorders, the approach for fibromyalgia management follows core principles of comprehensive assessment, education, goal setting, multimodal treatment including pharmacological (eg, pregabalin, duloxetine, milnacipran) and nonpharmacological therapies (eg, physical activity, behavioral therapy, sleep hygiene, education), and regular education and monitoring of treatment response and progress. Based on these core management principles, this review presents a framework for primary care providers through which they can develop a patient-centered treatment program for patients with fibromyalgia. This proactive and systematic treatment approach encourages ongoing education and patient self-management and is designed for use in the primary care setting.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560527      PMCID: PMC3498162          DOI: 10.1016/j.mayocp.2012.02.010

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  44 in total

1.  A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Authors:  Lesley M Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N D'Souza; David J Goldstein; Smriti Iyengar; Joachim F Wernicke
Journal:  Pain       Date:  2005-11-17       Impact factor: 6.961

2.  Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia.

Authors:  Saskia van Koulil; Wim van Lankveld; Floris W Kraaimaat; Toon van Helmond; Annemieke Vedder; Hanneke van Hoorn; Rogier Donders; Alphons J L de Jong; Joost F Haverman; Kurt-Jan Korff; Piet L C M van Riel; Hans A Cats; Andrea W M Evers
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

3.  Characterization and consequences of pain variability in individuals with fibromyalgia.

Authors:  Richard E Harris; David A Williams; Samuel A McLean; Ananda Sen; Michael Hufford; R Michael Gendreau; Richard H Gracely; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2005-11

Review 4.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

5.  Internet-enhanced management of fibromyalgia: a randomized controlled trial.

Authors:  David A Williams; David Kuper; Michelle Segar; Niveditha Mohan; Manish Sheth; Daniel J Clauw
Journal:  Pain       Date:  2010-09-19       Impact factor: 6.961

6.  A randomized, controlled clinical trial of education and physical training for women with fibromyalgia.

Authors:  C S Burckhardt; K Mannerkorpi; L Hedenberg; A Bjelle
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

7.  A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.

Authors:  Lesley M Arnold; I Jon Russell; E W Diri; W Rachel Duan; James P Young; Uma Sharma; Susan A Martin; Jeannette A Barrett; George Haig
Journal:  J Pain       Date:  2008-06-03       Impact factor: 5.820

Review 8.  Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials).

Authors:  Ernest H Choy; Philip J Mease
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

9.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

Review 10.  Classification, epidemiology, and natural history of fibromyalgia.

Authors:  K P White; M Harth
Journal:  Curr Pain Headache Rep       Date:  2001-08
View more
  33 in total

1.  Effects of exercise on physical limitations and fatigue in rheumatic diseases.

Authors:  Giuseppe Musumeci
Journal:  World J Orthop       Date:  2015-11-18

2.  Does it mean anything to diagnose fibromyalgia (FM) in somebody with chronic widespread pain?

Authors:  Luis Jose Catoggio
Journal:  Clin Rheumatol       Date:  2015-05-29       Impact factor: 2.980

Review 3.  Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden.

Authors:  Tracy L Skaer
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

Review 4.  Management of fibromyalgia syndrome in 2016.

Authors:  Akiko Okifuji; Jeff Gao; Christina Bokat; Bradford D Hare
Journal:  Pain Manag       Date:  2016-06-16

5.  Life among Chinese fibromyalgia patients: a cross-sectional study.

Authors:  Juan Jiao; Yang Li; Qiuwei Peng; Yayun Zhao; Quan Jiang
Journal:  Clin Rheumatol       Date:  2022-07-13       Impact factor: 3.650

6.  Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients.

Authors:  Lorenzo Bettoni; Felice Giulio Bonomi; Viviana Zani; Luigia Manisco; Annamaria Indelicato; Patrizia Lanteri; Giuseppe Banfi; Giovanni Lombardi
Journal:  Clin Rheumatol       Date:  2013-05-02       Impact factor: 2.980

7.  Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects.

Authors:  Xiao Zhang; Huji Xu; Zhiyi Zhang; Yang Li; Lynne Pauer; Shanmei Liao; Fengchun Zhang
Journal:  J Pain Res       Date:  2021-02-25       Impact factor: 3.133

8.  Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study.

Authors:  Lucinda Bateman; Robert H Palmer; Joel M Trugman; Yuhua Lin
Journal:  J Pain Res       Date:  2013-04-26       Impact factor: 3.133

9.  A patient and physician survey of fibromyalgia across Latin America and Europe.

Authors:  Patricia Clark; Eduardo S Paiva; Anna Ginovker; Patricia Arline Salomón
Journal:  BMC Musculoskelet Disord       Date:  2013-06-14       Impact factor: 2.362

10.  Extension trial of qigong for fibromyalgia: a quantitative and qualitative study.

Authors:  Jana Sawynok; Mary Lynch; Dana Marcon
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.